Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Pietschmann

Showing results (161-170 of 210) with videos related to

Pageof 21
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2021
Reverse genetics systems for contemporary isolates of respiratory syncytial virus enable rapid evaluation of antibody escape mutantsWendy K Jo, Alina Schadenhofer, Andre Habierski, et al.
Hepatology (Baltimore, Md.)|May 7, 2014
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agentsKoen Vercauteren, Naomi Van Den Eede, Ahmed Atef Mesalam, et al.
Gut|August 2, 2013
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cellsAnggakusuma, Che C Colpitts, Luis M Schang, et al.
Journal of Hepatology|June 14, 2015
Soraphen A: A broad-spectrum antiviral natural product with potent anti-hepatitis C virus activityGeorge Koutsoudakis, Inés Romero-Brey, Carola Berger, et al.
Hepatology (Baltimore, Md.)|September 13, 2014
Clinical course of infection and viral tissue tropism of hepatitis C virus-like nonprimate hepaciviruses in horsesStephanie Pfaender, Jessika M V Cavalleri, Stephanie Walter, et al.
Antimicrobial Agents and Chemotherapy|September 6, 2018
The Small-Compound Inhibitor K22 Displays Broad Antiviral Activity against Different Members of the Family Flaviviridae and Offers Potential as a Panviral InhibitorObdulio García-Nicolás, Philip V'kovski, Nathalie J Vielle, et al.
Hepatology (Baltimore, Md.)|October 20, 2012
The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral disseminationMuhammad N Zahid, Marine Turek, Fei Xiao, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 15, 2024
Dynamic Combinatorial Chemistry Unveils Nsp10 Inhibitors with Antiviral Potential Against SARS-CoV-2Ravindra P Jumde, Gwenaëlle Jézéquel, Margarida Saramago, et al.
Gastroenterology|May 15, 2012
Hepatocytes that express variants of cyclophilin A are resistant to HCV infection and replicationThomas von Hahn, Cordelia Schiene-Fischer, Nguyen Dinh Van, et al.
Viruses|March 22, 2019
Characterization of the Filovirus-Resistant Cell Line SH-SY5Y Reveals Redundant Role of Cell Surface Entry FactorsFrancisco J Zapatero-Belinchón, Erik Dietzel, Olga Dolnik, et al.
Pageof 21

Showing results (161-170 of 210) with videos related to

Sort By:
Pageof 21
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2021
Reverse genetics systems for contemporary isolates of respiratory syncytial virus enable rapid evaluation of antibody escape mutantsWendy K Jo, Alina Schadenhofer, Andre Habierski, et al.
Hepatology (Baltimore, Md.)|May 7, 2014
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agentsKoen Vercauteren, Naomi Van Den Eede, Ahmed Atef Mesalam, et al.
Gut|August 2, 2013
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cellsAnggakusuma, Che C Colpitts, Luis M Schang, et al.
Journal of Hepatology|June 14, 2015
Soraphen A: A broad-spectrum antiviral natural product with potent anti-hepatitis C virus activityGeorge Koutsoudakis, Inés Romero-Brey, Carola Berger, et al.
Hepatology (Baltimore, Md.)|September 13, 2014
Clinical course of infection and viral tissue tropism of hepatitis C virus-like nonprimate hepaciviruses in horsesStephanie Pfaender, Jessika M V Cavalleri, Stephanie Walter, et al.
Antimicrobial Agents and Chemotherapy|September 6, 2018
The Small-Compound Inhibitor K22 Displays Broad Antiviral Activity against Different Members of the Family Flaviviridae and Offers Potential as a Panviral InhibitorObdulio García-Nicolás, Philip V'kovski, Nathalie J Vielle, et al.
Hepatology (Baltimore, Md.)|October 20, 2012
The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral disseminationMuhammad N Zahid, Marine Turek, Fei Xiao, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 15, 2024
Dynamic Combinatorial Chemistry Unveils Nsp10 Inhibitors with Antiviral Potential Against SARS-CoV-2Ravindra P Jumde, Gwenaëlle Jézéquel, Margarida Saramago, et al.
Gastroenterology|May 15, 2012
Hepatocytes that express variants of cyclophilin A are resistant to HCV infection and replicationThomas von Hahn, Cordelia Schiene-Fischer, Nguyen Dinh Van, et al.
Viruses|March 22, 2019
Characterization of the Filovirus-Resistant Cell Line SH-SY5Y Reveals Redundant Role of Cell Surface Entry FactorsFrancisco J Zapatero-Belinchón, Erik Dietzel, Olga Dolnik, et al.
Pageof 21